Multiple Sclerosis (MS) is a chronic condition affecting the nervous system, including the brain, spinal cord, and optic nerves. In MS, the immune system mistakenly attacks the myelin sheath, a protective layer around nerves that ensures rapid signal transmission. This attack results in temporary lesions and cell inflammation, as well as permanent lesions and scars, which impede the brain's ability to transmit signals throughout the body.

According to the National Institute for Neurological Disorders and Stroke (NINDS), over 350,000 individuals in the United States have MS. The National Multiple Sclerosis Society estimates this number could exceed one million.

There are four distinct types of MS:

Primary Progressive Multiple Sclerosis (PPMS)

Relapse-remitting MS (RRMS)

Secondary progressive MS (SPMS)

Clinically isolated syndrome (CIS)

The primary cause of Multiple Sclerosis (MS) is autoimmune attacks on the body. These attacks can cross the blood-brain barrier and damage the protective myelin sheath around nerve fibers. Demyelination, the loss of myelin, leads to attempts at remyelination (formation of new myelin), but the inflammation often results in scar tissue formation. These scar tissues can cause neurological impairment in the affected nerves and areas.

There is no single known factor or cause of Multiple Sclerosis. Instead, a combination of factors and triggering stimuli lead to immune system abnormalities, causing it to act against its normal function.

Several factors can increase the risk of developing Multiple Sclerosis (MS):

Age and Gender: MS is most commonly diagnosed in individuals between the ages of 20 and 40. Additionally, women are more frequently affected by MS than men.

Infections: Exposure to certain viruses, such as Epstein-Barr Virus (EBV) and Mononucleosis, can elevate the risk of developing MS. Other viruses, including Mycoplasma pneumonia and Human Herpesvirus Type-6 (HHV6), may also contribute to triggering the immune system.

Nutrient Deficiency: Deficiencies in essential vitamins, particularly Vitamin D and B-12, can disrupt normal immune system function and contribute to neurological conditions like MS.

Smoking and Toxin Exposure

Chronic smokers are twice as likely to develop Multiple Sclerosis (MS) compared to non-smokers. This population also experiences more brain shrinkage and lesions than healthy individuals. Additionally, genetic and environmental factors can cause mutations in the genetic makeup, increasing the risk of MS.

MS is a disease of the central nervous system (CNS), which controls all bodily functions. Consequently, MS can affect almost any part of the body. The most common and significant symptoms include:

Muscular Weakness: Caused by nerve damage and reduced muscle use.

Tingling Sensation and Numbness

Bowel and Bladder Problems: Including difficulty emptying the bladder, urge incontinence, and loss of voluntary bladder control.

Vertigo and Dizziness: Leading to balance and coordination issues.

Symptoms of Multiple Sclerosis (MS)

Muscle spasms and spasticity are early signs of MS, indicating damage to nerve fibers in the brain and spinal cord. Additional common symptoms include:

Tremors and Uncontrolled Involuntary Movements

Vision-Related Issues: Due to damage to the optic nerve's myelin sheath, potentially leading to partial or complete vision loss.

Changes in Mobility and Gait Patterns

Sexual Dysfunction

Cognitive Issues: Including confusion, learning difficulties, memory problems, and pain.

Medications such as Cladribine (Mavenclad), Aubagio (Teriflunomide), Tecfidera (Dimethyl Fumarate), Lemtrada (Alemtuzumab), Tysabri (Natalizumab), Novantrone (Mitoxantrone), Siponimod (Mayzent), and Rebif and Avonex (Interferon beta 1-a) are effective in the initial stages but are not a cure.

 It is important to note that these medications are primarily effective in the early stages of MS and do not provide a complete cure for the disease.

Emerging data and evidence suggest that stem cell therapy holds great potential for regenerating the myelin sheath and reversing the effects of MS. Stem cell therapy offers a promising alternative to traditional treatment regimens for Multiple Sclerosis.

1.         Mesenchymal Cells for Multiple Sclerosis (MS)

Mesenchymal cells are mature stem cells found in the umbilical cord, adipose tissue, and bone marrow. These cells are anti-inflammatory, multipotent, and regenerative agents for the human body. Mesenchymal cells derived from the umbilical cord offer several advantages over other sources:

Ethical Validation

Less Invasive: Harvesting these cells is less invasive compared to other procedures.

Offer low immunogenicity

Offer high capacity for proliferation

Have a high capacity for differentiation in the body

Clinical Use of Mesenchymal Stem Cells in Disease Treatment

Several clinical studies have explored the use of mesenchymal stem cells (MSCs) to treat various diseases, including multiple sclerosis, Alzheimer's disease, and type 1 diabetes.

Neurological diseases, such as stroke, Parkinson's disease, and Alzheimer's disease, have high mortality and incapacitation rates, impairing the proper functioning of various parts of the brain. Traditional treatments for these conditions include endovascular thrombectomy (ET), intravenous tissue plasminogen activator (IV tPA), and other medications.

A modern approach to treating neurological disorders is the use of exosomes in conjunction with stem cell therapy. Research indicates that exosomes can enhance angiogenesis, ischemic border zone neurogenesis, neurite remodeling, and synaptic plasticity. Many researchers assert that combining stem cell therapy with exosomes can improve function, tissue level, and cellular recovery in individuals with neurological diseases and injuries.

Benefits of Exosomal Therapy Post-Stroke

Intravenous administration of mesenchymal stem cells, along with exosome therapy, can significantly improve white matter integrity post-stroke by inducing:

Oligodendrogenesis

Remyelination

Axonal sprouting

Additionally, exosomes enhance the expression of neuroprotective microRNAs, such as miR-133b, miR-210, miR-184, and the miR-17-92 cluster, contributing to a favorable prognosis.

Unique Treatment Approach at Renue Medical Center

The Renue Medical Center adopts a holistic approach to treating multiple sclerosis (MS) through stem cell therapy (SCT). The benefits of SCT for MS include:

Halting autoimmune attacks by the immune system

Promoting nerve tissue repair through central nervous system integration

Improving clinical prognosis by reducing demyelination and leukocyte infiltration in the central nervous system.

Reducing pro-inflammatory responses and ensuring good tolerance by the body.

At Renue we believe that if you are truly interested in Healthspan (Living better, not just longer.”) then it’s important that we are aware of our Biological Age vs Chronological Age.  Remember you can”t measure success without a starting point.  With TruDiagnostic’s TruAge testy you will receive 9 personalized Epigenetic Health Scores and actionable insights to slow aging

Biological Age

How old your body is compared to your real age

Pace of Aging

How quickly you're aging each year

Organ System Ages

The age of key organs (heart, brain, liver, etc.)

Fitness Age

Your physical health based on strength, lung capacity, and movement

Smoking Impact

How smoking has affected your epigenetic age

Alcohol Impact

How alcohol consumption has influenced your health